Methods This retrospective, database study used Optums de-identified Clinformatics Data Mart Database to identify glucagon-like peptide 1 receptor agonist (GLP-1 RA) treatment-nave adult patients with type 2 diabetes (T2D) initiating semaglutide QW, dulaglutide, liraglutide, or exenatide QW between January 1, 2018 and April 30, 2019
Furthermore, establishing a comprehensive safety and tolerability profile, particularly regarding long-term use and potential drug-drug interactions in the elderly AD population who often take multiple medications, is crucial
The guideline states that insufficient literature was identified to constitute an evidence base for diagnosis of IC/BPS in clinical practice
Drug-mediated ototoxicity and tinnitus: alleviation with melatonin
The first month often brings 13 pounds of weight loss as your body adjusts to reduced calorie intake from decreased hunger